Of what value is uracil/tegafur plus leucovorin to colorectal cancer patients?
Michael
M
Friedman
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D017277:Drug Approval; D006297:Health Services Accessibility; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D005641:Tegafur / Q000008:administration & dosage; D014481:United States; D014486:United States Food and Drug Administration; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D014498:Uracil; D002955:Leucovorin